Axiora Medical
Axiora Medical
Total Hip Arthroplasty (THA) stands as one of the most successful surgical interventions of the 21st century. At the core of its longevity lies the selection of articulation couples. Among these, the Metal-on-Polyethylene (MoP) interface remains the gold standard, providing a balanced solution of clinical performance, mechanical toughness, and cost efficiency. As premium manufacturers in China, we leverage ultra-high molecular weight polyethylene (UHMWPE) and highly cross-linked polyethylene (XLPE) paired with precision-ground Cobalt-Chromium-Molybdenum (CoCrMo) alloy heads to mitigate wear rates and combat osteolysis.
The principal mechanism of MoP failure in historical implant designs was wear-induced osteolysis, triggered by sub-micron polyethylene debris. Traditional UHMWPE, when sterilized via gamma irradiation in air, generated free radicals leading to long-term oxidation, structural embrittlement, and elevated wear rates. Modern Chinese production lines resolve this by cross-linking the polymer chains using high-dose electron beams or gamma irradiation in inert environments, followed by thermal annealing or mechanical deformation to eliminate residual free radicals. The result is a dramatic reduction in volumetric wear of up to 90%, offering active patients implant longevity exceeding 20 to 25 years.
Manufactured from ASTM F1537 / F75 CoCrMo alloy, delivering extreme surface hardness (>2500 HV) and optimized sphericity deviations under 0.5 microns to minimize friction.
We use premium raw materials (GUR 1020 / GUR 1050) subjected to controlled electron beam irradiation to maximize cross-linking density, achieving unmatched wear reduction.
Optionally infused with Vitamin E (Alpha-Tocopherol) acting as a powerful scavenger of free radicals, eliminating the need for thermal treatments that degrade mechanical strength.
Axiora Medical Technology (China) Co., Ltd. is a professional manufacturer specializing in the research, development, production, and global supply of high-quality orthopedic implants and surgical instruments. Our product portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and related orthopedic surgical instruments.
Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide. With strong OEM and ODM capabilities, we provide customized manufacturing services according to customers' drawings, samples, and technical requirements. From product design and prototyping to mass production and packaging, our integrated manufacturing process ensures consistent quality, competitive pricing, and on-time delivery. Today, Axiora exports its orthopedic products to customers across Europe, North America, South America, the Middle East, Southeast Asia, and Africa, building long-term partnerships with medical device distributors, brand owners, hospitals, and healthcare organizations around the world.
| Parameter Item | Manufacturing & Commercial Details |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand | Axiora |
| Website | www.axioraortho.com |
| Established | 2017 |
| Factory Area | 18,600 m² |
| Annual Export Revenue | USD 26 Million |
| Export Experience | 8 Years |
| Industry Experience | 15 Years |
| Quality Inspection | 100% Finished Product Inspection & Incoming Material Inspection |
| Product Inspection Methods | Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Testing |
| Quality Control Staff | 48 Professionals |
| Business Type | Manufacturer & Exporter (OEM/ODM) |
| Main Markets | Europe, North America, Middle East, Southeast Asia, South America |
| Supply Chain Partners | 1,120 global partners |
| Main Customer Types | Medical Device Brands, Importers, Distributors, Hospitals, Government Procurement Projects |
| R&D Capability | Independent Product Development, Reverse Engineering, OEM & ODM Solutions |
| Customization Options | Logo Printing, Private Label, Custom Packaging, Product Design, Material Selection, Drawing-Based Manufacturing |
| New Products Released Last Year | 126 Products |
| R&D Engineers | 86 Dedicated Engineers |
Axiora's industrial footprint integrates advanced mechanical engineering with a sterile, class-10,000 cleanroom environment. Every step of our joint reconstruction implant production—from raw bar stock processing to packing—follows strict global standard operating procedures (SOPs).
Procuring medical implants from China has shifted from a search for simple cost-arbitrage to a strategic integration of robust supply chain ecosystems. At Axiora, we consolidate raw materials, high-precision tooling, cleanroom packaging, and rapid R&D iteration within a centralized hub to minimize delivery cycles and overhead.
One of Axiora’s key competitive advantages lies in our long-term supply agreements with primary medical-grade raw material providers. For titanium alloy components (Ti6Al4V ELI conforming to ASTM F136), we rely on domestic aerospace-grade smelters capable of providing absolute melt batch traceability. For Ultra-High Molecular Weight Polyethylene (UHMWPE), we import premium GUR resins directly from Celanese (Ticona) to verify cross-linking behavior during processing. This dual domestic-global material pipeline shields our overseas buyers from pricing shocks and material shortfalls.
Our quality management system is audited under the Medical Device Single Audit Program (MDSAP). This streamlines registration in the US, Canada, Australia, Japan, and Brazil by utilizing a single unified quality audit report.
We provide full reverse-engineering services and custom OEM manufacturing based on customer blueprints. Our R&D center can take a prototype from CAD model to 3D titanium-printed sample in under 10 business days.
Understanding the inventory carrying costs for regional distributors, we support flexible Minimum Order Quantities (MOQ) per component dimension, coupled with air/sea door-to-door medical logistics.
Navigating the global regulatory landscape is a core hurdle for medical device distributors. Axiora provides full Technical Documentation Dossiers (TDD) for CE MDR (EU) 2017/745 compliance, FDA 510(k) applications, and domestic regulatory registrations in Latin America and the APAC region:
The choice of articulation couple in Total Hip Arthroplasty (THA) is dictated by patient age, activity index, anatomical geometry, and cost. While ceramic-on-ceramic (CoC) bearings offer exceptional hardness, they suffer from risk of brittle fracture and potential squeaking. Metal-on-Polyethylene (MoP) remains the ideal biomechanical fit for specific clinical populations.
Older demographics benefit from MoP due to its forgiving nature, low initial cost, and low risk of catastrophic component fracture. Volumetric wear is minimal under low-activity lifestyles.
Designed to address instability and recurrent dislocation, dual-mobility cups utilize a double articulation mechanism where a small metallic head articulates inside a large mobile XLPE liner.
For patients requiring complex revisions, MoP provides a highly adaptable bearing interface, reducing stresses at the bone-implant interface during high-impact loading.
The industry is transitioning toward combining the advantages of different materials. One key trend is "Ceramicized Metal" heads (such as Oxidized Zirconium), which match the scratch resistance of ceramics while retaining the structural ductility of metals. Paired with next-generation Vitamin E stabilized highly cross-linked polyethylene (VE-XLPE), this combination maintains high fatigue strength and resistance to delamination, keeping wear rates under 1 mm³ per million cycles in simulated testing.
